Scientists probe growth Hormone's role in prediabetes to unlock diabetes clues

NCT ID NCT07581860

Not yet recruiting Knowledge-focused Sponsor: University of Missouri-Columbia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study looks at how beta-cells (which make insulin) respond to growth hormone in people with prediabetes. Researchers will measure insulin release in 10 adults with impaired fasting glucose or impaired glucose tolerance. The goal is to better understand what raises the risk of developing type 2 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance Obesity obesity disorder Overweight prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY IMPAIRED FASTING GLUCOSE (IFG) IMPAIRED GLUCOSE TOLERANCE (PREDIABETES) OBESITY & OVERWEIGHT

Contacts and locations

Locations

University of Missouri School of Medicine

Columbia, Missouri, 65212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.